MBMarc Blanchard

Marc Blanchard

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Marc Blanchard has a total of 50 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Smartphone Imaging for Remote Monitoring of Inflammatory Arthritis in a Real-World Cohort: Longitudinal Evaluation of a Machine Learning-Based Finger Fold Biomarker

    by Cinja Nadana Koller, Jules Maglione, Marc Blanchard, Alexandre Dumusc, Diana Dan, Laure Brulhart, Michael Nissen, Michael Andor, Raphael Micheroli, Almut Scherer, et al.

    Background: Smartphone enabled remote patient monitoring has the potential to complement conventional follow-up in inflammatory arthritis. We previously presented the finger fold index (FFI) derived from hand photographs as ratio of automated detected proximal interphalangeal (PIP) joint diameter and surface of dorsal finger folds as a digital biomarker for clinical joint swelling and disease activity in rheumatoid arthritis (RA) and psoriatic arthritis (PsA). Objective: To evaluate the feasibility, image quality, patient engagement, and clinical utility of both HCP- and patient-collected hand photographs integrated into a national rheumatology registry, and to assess the performance of the FFI as an image-derived digital biomarker for clinical joint swelling of the proximal interphalangeal joints in a real-world arthritis cohort. Methods: In this longitudinal multicenter study, a photo function with written instructions were integrated into the Swiss Clinical Quality Management in Rheumatic Diseases (SCQM) registry and their mySCQM mobile application, respectively. Patients with RA or PsA contributed longitudinal smartphone photographs together with patient-reported outcomes (PROs) via the mySCQM mobile application while health care professionals (HCPs) acquired images during routine visits. After manual quality assessment, images were processed using an automated computer vision pipeline to derive the FFI, a digital biomarker based on dorsal finger-fold morphology. Image quality was evaluated for both HCP- and participant-collected photographs, and patient engagement was assessed. Associations between FFI, clinical proximal interphalangeal (PIP) joint swelling, RADAI-5, DAS28-CRP and longitudinal changes were assessed. A generalized linear mixed model was used to estimate the association between FFI and joint swelling while accounting for repeated measures and within-subject correlations. Results: Between 2023 and 2025, 374 RA and PsA patients were included. HCPs captured 977 hand images while 174 patients collected 1228 hand images via the mySCQM app. Patients demonstrated sustained engagement after instruction, contributing a mean of seven images during data collection. Following quality control, 1729 hand images comprising 4048 PIP joints were included for analysis. Image quality was comparable between patient-acquired and HCP-acquired photographs; 78.3% of the patient-acquired vs. 73.5% of the HCP-acquired hand images were suitable to run the ML-model. 23.1% of the cropped joints had to be removed after the running of the FFI algorithm due to false diameter or finger fold detection e.g. due to wrong hand positioning. In images taken by HCPs, mean FFI and DAS28-CRP were weakly but significantly correlated (Spearman’s ρ = 0.164; 95% CI [0.004 to 0.317]; p = 0.039). Conversely, RADAI-5 scores did not correlate with the mean FFI in RA patients (r = 0.007, p = 0.932, 95% CI [-0.169-0.183]). At follow-up visits, clinical swelling resolved in 40 joints, of which in 68.0% the direction of the delta FFI was concordant with the clinical change. In contrast, 13 joints developed incident clinical swelling, of which 87.5% had a direction of the delta FFI that was concordant with the clinical change. However, the GLMM showed no significant associations between swelling and joint location or time-varying FFI, and no evidence of interaction between FFI and PIP joint. Conclusion: Integration of patient self-imaging into a remote monitoring application for inflammatory arthritis is feasible and achieves image quality comparable to clinician acquired photographs. The FFI derived from collected images shows association with clinical joint swelling and disease activity scores, but not PROs. In a substantial proportion of images, the FFI algorithm could not be applied because of insufficient image quality. More standardized image acquisition and further refinement of the FFI algorithm are warranted.

  • Open Access

    Impact of Different Onboarding Strategies on Low Adoption and Engagement With a Self-Monitoring and Management App for Chronic Musculoskeletal Pain: Prospective Study

    by Cinja Nadana Koller, Marc Blanchard, Johanna Mettler, Tiffany Prétat, Pedro Ming Azevedo, Thomas Hügle

    Background: Suboptimal adoption and engagement rates of digital health applications present challenges to their effectiveness, particularly in chronic disease management such as fibromyalgia. Up to half of patients do not download the prescribed digital health applications or actively engage with them, making effective onboarding a critical opportunity for improvement. Objective: We aimed to investigate the impact of 3 different patient onboarding strategies on adoption, adherence, and engagement with a digital health application for the symptom management of chronic pain syndromes. Methods: We conducted a 4-week nonrandomized prospective study comprising patients (aged ≥18 years) with chronic musculoskeletal pain who fulfilled the fibromyalgia criteria and were using a new self-monitoring and management application after onboarding. The pain organizer and companion system consists of symptom reporting, symptom monitoring, and an advice and exercise section. Participants in group 1 (standard) received an email-based onboarding with detailed instructions on application download, registration, use, usability data capture, data security, and study procedures without any in-person assistance. Group 2 (video) received the same email plus a video tutorial explaining the application’s use also without any in-person assistance. Group 3 (assisted) underwent an enhanced in-person onboarding, which included hands-on support for application setup and guided instructions from a health care professional. Primary outcomes included adoption, engagement, and adherence, measured respectively by successful application download with at least 1 log-in, cumulative activations, and connection at least once per week over 4 weeks. Results: A total of 48 patients were recruited (mean age 45.7, SD 12.2; range 19-79 years). In the assisted group, all 15 participants in the assisted onboarding group downloaded the application compared to 63% (10/16) in the standard group and 77% (13/17) in the video group. A significant difference in adoption between the in-person onboarding group (group 3) and the remote groups (groups 1 and 2) with P=.009 was observed. Overall engagement, measured by cumulative app activation, ranged between 0 and 28 log-ins, with no significant difference (P=.18) in mean log-ins across the 3 groups. Overall adherence was low with 27% (13/48) of participants meeting adherence criteria and a retention rate of 46% (22/48) at week 4. Responses to the System Usability Scale survey were limited to 8 responses but achieved a score of 70.31, indicating good usability of the application. Conclusions: Unassisted downloading and account creation might be barriers to adopting a digital health app among patients with chronic musculoskeletal pain.


  • Open Access

    Evidence-Based Self-Management Strategies for Fibromyalgia: Foundations for Digital Therapeutic Applications

    by Thomas Lebeau Foustoukos, Isabelle Leclercq, Marc Blanchard, Thomas Hügle

    Fibromyalgia is a prevalent musculoskeletal pain condition that causes major personal, social, and societal burden. Pharmacological therapies often provide only limited benefit, making multimodal approaches and self-management the cornerstones of care. Such strategies, spanning lifestyle modification, physical activity, psychoeducation, and cognitive-behavioral approaches, target the biopsychosocial complexity of fibromyalgia and promote sustainable coping. In parallel, digital health technologies are transforming how these interventions can be delivered and coordinated in the form of digital therapeutics. This viewpoint draws on a multiphase investigation to appraise the current and future landscape of fibromyalgia self-management in the digital era. Its objective is to present an evidence-based framework and recommendations to guide the development of a mobile health self-management program for patients with fibromyalgia. In phase 1, we conducted a review of international guidelines and randomized controlled trial–based systematic reviews addressing nondigital self-management interventions for fibromyalgia and related nociplastic pain conditions. In phase 2, we analyzed the content and certification status of currently available mobile and virtual health applications for fibromyalgia. In phase 3, we convened a multidisciplinary focus group of rheumatologists, patients, and digital health developers to identify priorities for translating evidence-based self-management content into mobile health formats. Collectively, we suggest that effective digital self-management for fibromyalgia should evolve beyond single-domain interventions toward validated, personalized, and interactive multimodal platforms. Virtual care may increasingly function at the point of care, linking monitoring, education, and behavioral support in one continuum.


  • Open Access

    Navigating through regulatory frameworks for digital therapeutics and biomarkers

    by Cinja Koller, Marc Blanchard, Thomas Hügle

    Background: Digital health technologies are often subject to regulatory requirements. Regulatory auditing processes are complex but necessary to guarantee quality, efficacy and safety of patients. Evolvements such as digitalized clinical trials, and digital biomarkers require a constant adaption of regulatory frameworks. Objective: This review aims to provide an overview on current regulations and standards for digital therapeutics and digital biomarkers, from technical development to market access. Methods: We conducted an unstructured literature review to identify the relevant guidelines, policies and standards for software based digital therapeutics and digital biomarkers. Results: The principal regulations governing software as a medical device are outlined in Chapter 21 of the Code of Federal Regulations by the US Food and Drug Administration, as well as the European Medical Device Regulation 2017/745. Regulatory pathways, such as the DiGA, are in the process of development, particularly for digital therapeutics, which fall within the purview of software as a medical device. Qualification of (digital) biomarkers is typically voluntary but can play a significant role in the development and approval of digital therapeutics. Conclusions: Fragmented, lacking and diverse regulations around digital biomarkers and digital therapeutics highlight the urge to harmonize and foster regulatory frameworks on an international level.


  • Open Access

    Five years of the Digital Rheumatology Network: insights and future directions

    by Antoni Chan, Johannes Knitza, Vincenzo Venerito, Latika Gupta, Jutta G. Richter, Philip Hamann, Didier Hans, Martin Krusche, Bart van Den Bempt, Jacob M. van Laar, et al.


  • Open Access

    Impact of Different Onboarding Strategies on Low Adoption and Engagement With a Self-Monitoring and Management App for Chronic Musculoskeletal Pain: Prospective Study (Preprint)

    by Cinja Nadana Koller, Marc Blanchard, Johanna Mettler, Tiffany Prétat, Pedro Ming Azevedo, Thomas Hügle

    BACKGROUND Suboptimal adoption and engagement rates of digital health applications present challenges to their effectiveness, particularly in chronic disease management such as fibromyalgia. Up to half of patients do not download the prescribed digital health applications or actively engage with them, making effective onboarding a critical opportunity for improvement. OBJECTIVE We aimed to investigate the impact of 3 different patient onboarding strategies on adoption, adherence, and engagement with a digital health application for the symptom management of chronic pain syndromes. METHODS We conducted a 4-week nonrandomized prospective study comprising patients (aged ≥18 years) with chronic musculoskeletal pain who fulfilled the fibromyalgia criteria and were using a new self-monitoring and management application after onboarding. The pain organizer and companion system consists of symptom reporting, symptom monitoring, and an advice and exercise section. Participants in group 1 (standard) received an email-based onboarding with detailed instructions on application download, registration, use, usability data capture, data security, and study procedures without any in-person assistance. Group 2 (video) received the same email plus a video tutorial explaining the application’s use also without any in-person assistance. Group 3 (assisted) underwent an enhanced in-person onboarding, which included hands-on support for application setup and guided instructions from a health care professional. Primary outcomes included adoption, engagement, and adherence, measured respectively by successful application download with at least 1 log-in, cumulative activations, and connection at least once per week over 4 weeks. RESULTS A total of 48 patients were recruited (mean age 45.7, SD 12.2; range 19-79 years). In the assisted group, all 15 participants in the assisted onboarding group downloaded the application compared to 63% (10/16) in the standard group and 77% (13/17) in the video group. A significant difference in adoption between the in-person onboarding group (group 3) and the remote groups (groups 1 and 2) with P=.009 was observed. Overall engagement, measured by cumulative app activation, ranged between 0 and 28 log-ins, with no significant difference (P=.18) in mean log-ins across the 3 groups. Overall adherence was low with 27% (13/48) of participants meeting adherence criteria and a retention rate of 46% (22/48) at week 4. Responses to the System Usability Scale survey were limited to 8 responses but achieved a score of 70.31, indicating good usability of the application. CONCLUSIONS Unassisted downloading and account creation might be barriers to adopting a digital health app among patients with chronic musculoskeletal pain.

  • Open Access

    Evidence-Based Self-Management Strategies for Fibromyalgia: Foundations for Digital Therapeutic Applications (Preprint)

    by Thomas Lebeau Foustoukos, Isabelle Leclercq, Marc Blanchard, Thomas Hügle

    UNSTRUCTURED Fibromyalgia is a prevalent musculoskeletal pain condition that causes major personal, social, and societal burden. Pharmacological therapies often provide only limited benefit, making multimodal approaches and self-management the cornerstones of care. Such strategies, spanning lifestyle modification, physical activity, psychoeducation, and cognitive-behavioral approaches, target the biopsychosocial complexity of fibromyalgia and promote sustainable coping. In parallel, digital health technologies are transforming how these interventions can be delivered and coordinated in the form of digital therapeutics. This viewpoint draws on a multiphase investigation to appraise the current and future landscape of fibromyalgia self-management in the digital era. Its objective is to present an evidence-based framework and recommendations to guide the development of a mobile health self-management program for patients with fibromyalgia. In phase 1, we conducted a review of international guidelines and randomized controlled trial–based systematic reviews addressing nondigital self-management interventions for fibromyalgia and related nociplastic pain conditions. In phase 2, we analyzed the content and certification status of currently available mobile and virtual health applications for fibromyalgia. In phase 3, we convened a multidisciplinary focus group of rheumatologists, patients, and digital health developers to identify priorities for translating evidence-based self-management content into mobile health formats. Collectively, we suggest that effective digital self-management for fibromyalgia should evolve beyond single-domain interventions toward validated, personalized, and interactive multimodal platforms. Virtual care may increasingly function at the point of care, linking monitoring, education, and behavioral support in one continuum.

  • Open Access

    Patients with refractory musculoskeletal pain syndromes undergoing a multimodal assessment and therapy programme: a cross-sectional study

    by Tiffany Prétat, Thomas Hügle, Johanna Mettler, Marc Suter, Sandy Jean Scherb, Reine-Laure Taily, Charlotte Hans, Marielle Hoarau, Laurent Monod, Pierre Frossard, et al.

    BACKGROUND: Chronic musculoskeletal pain syndromes, including fibromyalgia, are heterogeneous entities with a major socioeconomic burden. Multimodal treatment programmes have shown greater efficacy than conventional approaches for these patients, at least in the short term. A profound understanding of chronic musculoskeletal pain syndrome patients treated in multimodal treatment programmes is important for their development and to provide insight into these conditions. AIM: To provide a comprehensive and objective description of medical, psychosocial and sleep characteristics of the treatment-refractory chronic musculoskeletal pain syndrome patients treated at the multimodal treatment programmes provided by our tertiary service in Switzerland. METHODS: This was a cross-sectional analysis of 202 refractory chronic musculoskeletal pain syndrome patients with or without a concomitant autoimmune disorder hospitalised between 2018 and 2022 in a 12-day Swiss multimodal treatment programme. They underwent a comprehensive self-assessment with eight different questionnaires and assessments by a psychiatrist, rheumatologist, pain specialist, occupational therapist and physiotherapist. Sleep assessment was performed via actigraphy. Clinical and demographic variables were selected by consensus of three experienced rheumatologists and chronic pain specialists. The Fibromyalgia Rapid Screening Test (FiRST), American College of Rheumatology (ACR)-2010 criteria (ACR2010) and Toronto Alexithymia Scale-20 (TAS-20) were also applied. RESULTS: The mean age of the patients was 47 years (SD = 10), 73% were female, and 30% were obese. Half (50%) were not from Switzerland, and 12% came from conflict zones. Almost half (40%) lived alone. Back pain was the principal site (90%). Of the patients, 78% fulfilled the ACR2010 criteria for fibromyalgia, and 17% were diagnosed with an underlying immune-mediated disorder, mostly spondylarthritis. Pain since childhood occurred in 45% of the patients, and 68% had pain since adolescence. Disability financial aid had been pursued by 69%, and 46% were still awaiting a response. Psychiatric comorbidities were highly prevalent (73%), of which 56% consisted of depression. Of all patients, 15% were diagnosed with enduring personality changes after a catastrophic experience (EPCACE), and 10% had post-traumatic stress disorder. Alexithymia affected 34% of patients. Objective sleep disorder was observed in 78% of patients, and 41% were under opioid therapy. CONCLUSION: This analysis reveals the complex psychosomatic and socioeconomic patterns of the patients treated in Switzerland with refractory chronic musculoskeletal pain syndromes, often originating in childhood and adolescence. Obesity, immigration, social isolation, psychiatric comorbidities, sleep deprivation and opiate use, among others, stood out as target characteristics for further research.


  • Open Access

    Development of a Management App for Postviral Fibromyalgia-Like Symptoms: Patient Preference-Guided Approach

    by Marc Blanchard, Cinja Nadana Koller, Pedro Ming Azevedo, Tiffany Prétat, Thomas Hügle

    Background: Persistent fibromyalgia-like symptoms have been increasingly reported following viral infections, including SARS-CoV-2. About 30% of patients with post–COVID-19 syndrome fulfill the fibromyalgia criteria. This complex condition presents significant challenges in terms of self-management. Digital health interventions offer a viable means to assist patients in managing their health conditions. However, the challenge of ensuring their widespread adoption and adherence persists. This study responds to this need by developing a patient-centered digital health management app, incorporating patient preferences to enhance usability and effectiveness, ultimately aiming to improve patient outcomes and quality of life. Objective: This research aims to develop a digital health self-management app specifically for patients experiencing postviral fibromyalgia-like symptoms. By prioritizing patient preferences and engagement through the app’s design and functionality, the study intends to facilitate better self-management practices and improve adherence. Methods: Using an exploratory study design, the research used patient preference surveys and usability testing as primary tools to inform the development process of the digital health solution. We gathered and analyzed patients’ expectations regarding design features, content, and usability to steer the iterative app development. Results: The study uncovered crucial insights from patient surveys and usability testing, which influenced the app’s design and functionality. Key findings included a preference for a symptom list over an automated chatbot, a desire to report on a moderate range of symptoms and activities, and the importance of an intuitive onboarding process. While usability testing identified some challenges in the onboarding process, it also confirmed the importance of aligning the app with patient needs to enhance engagement and satisfaction. Conclusions: Incorporating patient feedback has been a significant factor in the development of the digital health app. Challenges encountered with user onboarding during usability testing have highlighted the importance of this process for user adoption. The study acknowledges the role of patient input in developing digital health technologies and suggests further research to improve onboarding procedures, aiming to enhance patient engagement and their ability to manage digital health resources effectively. International Registered Report Identifier (IRRID): RR2-10.2196/32193


  • Open Access

    Development of a Management App for Postviral Fibromyalgia-Like Symptoms: Patient Preference-Guided Approach (Preprint)

    by Marc Blanchard, Cinja Nadana Koller, Pedro Ming Azevedo, Tiffany Prétat, Thomas Hügle

    BACKGROUND Persistent fibromyalgia-like symptoms have been increasingly reported following viral infections, including SARS-CoV-2. About 30% of patients with post–COVID-19 syndrome fulfill the fibromyalgia criteria. This complex condition presents significant challenges in terms of self-management. Digital health interventions offer a viable means to assist patients in managing their health conditions. However, the challenge of ensuring their widespread adoption and adherence persists. This study responds to this need by developing a patient-centered digital health management app, incorporating patient preferences to enhance usability and effectiveness, ultimately aiming to improve patient outcomes and quality of life. OBJECTIVE This research aims to develop a digital health self-management app specifically for patients experiencing postviral fibromyalgia-like symptoms. By prioritizing patient preferences and engagement through the app’s design and functionality, the study intends to facilitate better self-management practices and improve adherence. METHODS Using an exploratory study design, the research used patient preference surveys and usability testing as primary tools to inform the development process of the digital health solution. We gathered and analyzed patients’ expectations regarding design features, content, and usability to steer the iterative app development. RESULTS The study uncovered crucial insights from patient surveys and usability testing, which influenced the app’s design and functionality. Key findings included a preference for a symptom list over an automated chatbot, a desire to report on a moderate range of symptoms and activities, and the importance of an intuitive onboarding process. While usability testing identified some challenges in the onboarding process, it also confirmed the importance of aligning the app with patient needs to enhance engagement and satisfaction. CONCLUSIONS Incorporating patient feedback has been a significant factor in the development of the digital health app. Challenges encountered with user onboarding during usability testing have highlighted the importance of this process for user adoption. The study acknowledges the role of patient input in developing digital health technologies and suggests further research to improve onboarding procedures, aiming to enhance patient engagement and their ability to manage digital health resources effectively. INTERNATIONAL REGISTERED REPORT RR2-10.2196/32193